The clinical relevance of urine-based markers for diagnosis of bladder cancer.
about
Urine telomerase for diagnosis and surveillance of bladder cancer.Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancerUrinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.[Urine cytology - update 2013. A systematic review of recent literature].Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
P2860
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@en
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@nl
type
label
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@en
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@nl
prefLabel
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@en
The clinical relevance of urine-based markers for diagnosis of bladder cancer.
@nl
P2093
P2860
P1433
P1476
The clinical relevance of urine-based markers for diagnosis of bladder cancer
@en
P2093
Galila Ahmed Yacout
Menha Swellam
Tarek Mostafa El-Zayat
P2860
P2888
P304
P356
10.1007/S12032-010-9422-6
P577
2011-03-25T00:00:00Z